The Board of Directors of Guizhou Bailing Group Pharmaceutical Co., Ltd. has authorized a buyback plan on February 2, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.83 CNY | -5.05% | -9.75% | -28.11% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.11% | 1.18B | |
+43.96% | 6.32B | |
-15.56% | 4.49B | |
-6.52% | 3.3B | |
+5.47% | 3.19B | |
-0.76% | 2.6B | |
+56.34% | 2.05B | |
-4.11% | 1.77B | |
+2.93% | 1.7B | |
-8.02% | 1.63B |
- Stock Market
- Equities
- 002424 Stock
- News Guizhou Bailing Group Pharmaceutical Co., Ltd.
- Guizhou Bailing Group Pharmaceutical Co., Ltd. authorizes a Buyback Plan.